baber/WOPTO huggingface dataset:
Patent IL-124682-A0 (IL)
Title: Digital anti-counterfeiting software method and apparatus
IPC: G06K19/00
Filed: 1996-11-26
Abstract: This invention relates generally to a method and apparatus, as implemented by a software program on a computer system, for digitally producing counterfeit-deterring scrambled or coded indicia images, typically in a printed form. This method and system are capable of combining a source image with a latent image so the scrambled latent image is visible only when viewed through a special decoder lens. The digital processing allows different latent images to be encoded according to different parameters. Additionally, latent images might be encoded into single component colors of an original visible image, at various angles from each other.
Patent IL-128672-A0 (IL)
Title: A process for the production of solid pharmaceutical forms
IPC: A61J3/00
Filed: 1997-09-11
Abstract: A process for producing solid dose forms by mixing at least one polymeric binder, with or without at least one active ingredient and with or without conventional additives, and shaping the mixture, where at least one of the components is employed in liquid form.
Patent IL-128779-A0 (IL)
Title: Method for recombinant adeno-associated virus-directed gene therapy
IPC: A61K48/00
Filed: 1997-09-04
Abstract: The present invention relates to the use of a recombinant adeno-associated virus (rAAV) for the manufacture of a medicament for reducing the immune response to the rAAV on administration of the medicament to a skeletal muscle cell, the rAAV being substantially free of contamination with helper virus. Pharmaceutical compositions comprising the rAAV are also described.
Patent IL-129139-A0 (IL)
Title: Vertebrate smoothened proteins
IPC: C07K19/00
Filed: 1997-09-29
Abstract: Novel vertebrate homologues of Smoothened, including human and rat Smoothened, are provided. Compositions including vertebrate Smoothened chimeras, nucleic acid encoding vertebrate Smoothened, and antibodies to vertebrate Smoothened, are also provided.
Patent IL-134296-A0 (IL)
Title: Methods for preserving fresh fruit and product thereof
IPC: A23B7/158
Filed: 1998-08-10
Abstract: Methods of preserving fresh fruit with fresh fruit preservatives which extend the shelf life of fresh fruit particularly fresh cut fruit, are provided. The fresh fruit preservative preserves the texture, flavor, appearance, crispness, and color of the fresh fruit, particularly the exposed skin of the fresh fruit. The method comprises the following steps: providing a solution of fruit preservative comprising: water, calcium ions; and ascorbate ions, wherein the calcium ion and ascorbate ions are present in a ion ratio of preferably from about 1.5:1 to about 2.5:1; and, applying said fruit preservative to the fruit. Preferably the fruit is then stored at a temperature which will not freeze the fruit; temperatures of -6 °C have been found not to freeze the apples. Preferably the fruit is stored at temperatures of between about -7 °C to room temperature, about 20 °C, more preferably about -2 °C to about 7 °C, most preferably from about 2 °C to about 5 °C. The invention also relates to fresh fruits preserved with the fresh fruit preservatives.
Patent IL-135148-A0 (IL)
Title: A polysaccharide conjugate and pharmaceutical compositions containing the same
IPC: C08B37/06
Filed: 1998-10-02
Abstract: The present invention relates to polysaccharide conjugates that comprise: a polysaccharide that binds to surface-receptors present on Antigen Presenting Cells, conjugated to one or more compounds having stable carbonyl groups covalently attached, either directly or via a bifunctional linker. The conjugates are useful as immuno-stimulants and adjuvants.
Patent IL-138033-A0 (IL)
Title: Method of preventing the death of retinal neurons and treating ocular diseases
IPC: A61P27/02
Filed: 1999-03-10
Abstract: The present invention relates to the use of FGF-5 polypeptides to delay, prevent or rescue retinal neurons, including photoreceptors, other retinal cells or supportive cells (e.g. Müller cells or RPE cells) from injury and degradation. Conditions comprehended by treatment of the present FGF-5 polypeptides (including variants), antibodies, compositions and articles of manufacture include: retinal detachment, age-related and other maculopathies, photic retinopathies, surgery-induced retinopathies (either mechanicallyy or light-induced), toxic retinopathies including those resulting from foreign bodies in the eye, diabetic retinopathies, retinopathy of prematurity, viral retinopathies such as CMV or HIV retinopathy related to AIDS, uveities, ischemic retinopathies due to venous or arterial occlusion or other vascular disorder, retinopathies due to trauma or penetrating lesions of the eye, peripheral vitreoretinopathy, and inherited retinal degenerations. Exemplary retinal degenerations include e.g., hereditary spastic paraplegia with retinal degeneration (Kjellin and Barnard-Scholz syndromes), retinis pigmentosa, Stargardt disease, Usher syndrome (retinits pigmentosa with congenital hearing loss), and Refsum syndrome (retinitis pigmentosa, hereditary hearing loss, and polyneuropathy). Additional disorders which result in death of retinal neurons include, retinal tears, detachment of the retina and pigment epithelium, degenerative myopia, acute retinal necrosis syndrome (ARN), traumatic chorioretinopathies or contusion (Purtscher's Retinopathy) and edema.
Patent IL-138600-A0 (IL)
Title: Multi-tine lifting implement
IPC: B66F9/12
Filed: 1999-03-31
Abstract: The present invention relates to a multi-tine lifting implement, which, when mounted on a vehicle such as a skid steer loader, can pry and lift objects such as concrete or asphalt slabs or pavement, pieces of concrete or asphalt, rocks, shrubs, small trees, and the like.
Patent IL-164486-A0 (IL)
Title: A semi-synthetic process for the preparation of n-debenzoylpaclitaxel
IPC: C07B51/00
Filed: 2003-03-24
Abstract: A process for the preparation of N-debenzoylpaclitaxel (I) through esterification of 7-protected baccatin III with a carboxylic acid reactive derivative of general formula (II), and elimination of the ester-protecting groups in acid conditions and in a single step. In formula (II) R1 is aryl or heteroaryl. The compound of formula (I) can be conveniently used for the preparation of paclitaxel and analogues
Patent IL-165605-A0 (IL)
Title: Molecular antigen arrays
IPC: C07K16/40
Filed: 2004-12-07
Abstract: The present invention provides a composition comprising an AP205 virus like particle (VLP) and an antigen. The invention also provides a process for producing an antigen or antigenic determinant bound to AP205 VLP. AP205 VLP bound to an antigen is useful in the production of compositions for inducing immune responses that are useful for the prevention or treatment of diseases, disorders or conditions including infectious diseases, allergies, cancer, drug addiction, poisoning and to efficiently induce self-specific immune responses, in particular antibody responses.
Patent IL-186271-A0 (IL)
Title: Multi-layer catalyst for producing phthalic anhydride
Filed: 2007-09-25
Abstract: The present invention relates to a catalyst for preparing phthalic anhydride by gas phase oxidation of o-xylene and/or naphthalene, comprising at least three catalyst zones which have different compositions and, from the gas inlet side toward the gas outlet side, are referred to as first, second and third catalyst zone, the catalyst zones having in each case an active composition comprising TiO2 with a content of Na of less than 0.3% by weight, and the active composition content decreasing from the first catalyst zone disposed toward the gas inlet side to the third catalyst zone disposed toward the gas outlet side, with the proviso that (a) the first catalyst zone has an active composition content between about 7 and 12% by weight, (b) the second catalyst zone has an active composition content in the range between 6 and 11% by weight, the active composition content of the second catalyst zone being less than or equal to the active composition content of the first catalyst zone, and (c) the third catalyst zone has an active composition content in the range between 5 and 10% by weight, the active composition content of the third catalyst zone being less than or equal to the active composition content of the second catalyst zone. Also described is a preferred process for preparing such a catalyst and the preferred use of the titanium dioxide used in accordance with the invention.
Patent IL-200960-A0 (IL)
Title: A cable cutter device
Filed: 2009-09-15
Abstract: A device (10) for cutting through cables (6) is provided with a jaw (30) having a top portion (31) and a bottom portion (32) which together define a notch (35). The device (10) is provided with a first and second stationary and co-operating sharp edges (33, 34) arranged at a downstream end (35′) of the notch (35) so as to form an angle between each other. The device further includes a rotary blade (50) provided with a body (51) having a tapering side (52), the body (51) being fastened to one of the portions (31, 32) of the jaw (33) so that the tapering side (52) is arranged in the notch (35) upstream from the first and second sharp edges (33, 34).
Patent IL-209818-A0 (IL)
Title: Process for manufacturing polyolefin films
Filed: 2010-12-07
Abstract: A process for manufacturing a film of ultra-high molecular weight polyolefin includes (a) feeding an ultra-high molecular weight polyethylene with a weight average molecular weight of at least 500,000 gram/mole as a powder having a bulk density below 0.5 g/cm3 to a compaction zone of an isobaric double belt press; (b) subjecting the ultra-high molecular weight polyethylene powder in the compaction zone to an isobaric pressure to form a single layer sheet of compacted polyethylene at a temperature that is below the melting point of the polyethylene under process conditions and that is maintained within a temperature window of 2° C.; and (c) subjecting the sheet of compacted polyethylene to a rolling step and at least one stretching step at a temperature below the melting point of the polyethylene under process conditions.
Patent IL-248493-A0 (IL)
Title: Method to increase class i presentation of exogenous antigens by human dendritic cells
IPC: A61K35/50
Filed: 2016-10-25
Abstract: The present invention relates to a method for increasing the uptake, processing and class I presentation of a soluble antigen by an immature dendritic cells, comprising the steps of: 
a) obtaining a population comprising human immature dendritic cells; 
b) culturing the population immature dendritic cells  in vitro  in a cell culture medium supplemented with a agent that promotes Major-Histocompatability Complex - (MHC-) class I processing and a soluble antigen associated with a tumor cell for a time period sufficient for antigen uptake, processing and presentation, and until maturation of the immature dendritic cells in the population; 
c) separating the soluble tumor antigen and the agent that promotes MHC-class I processing from the mature tumor antigen presenting dendritic cells; and 
d) formulating the mature tumor antigen presenting dendritic cells for administration to a patient.
Patent ZW-8390-A1 (ZW)
Title: 3-hydroxybutyrate polymer composition
Inventor: JOHN MICHAEL HERRING
IPC: C08K13/02
Filed: 1990-05-28
Abstract: A polyhydroxyalkanoate composition in which organophosphonic or organophosphinic acids, esters and derivatives thereof together with oxides, hydroxides or carboxylic acid salts of Group I to V metals are included as nucleating agents., A process for the production of the composition is also claimed. The composition is particularly a 3-hydroxybutyrate polymer composition.
Patent IE-910417-A1 (IE)
Title: Cryopreservation process for direct transfer of embryos
IPC: C12N5/06
Filed: 1991-02-08
Abstract: An improved cryopreservation of embryos has been developed. After freezing in a cryoprotective solution of ethylene glycol, dimethyl sulfoxide, glycerol or a combination thereof, the embryos can be thawed and transferred directly to the recipient animal without serial rehydration. The transfer can be made directly from the cryoprotective container to the recipient animal.
Patent MA-28315-A1 (MA)
Title: Nouvelle conception d'une vanne avec tige a cannelures
Inventor: CHBAIBA MOHAMED
Filed: 2005-05-10
Abstract: La présente invention concerne une nouvelle conception des robinets pour les canalisations d'alimentation en eau potable. Cette vanne comporte une tête (1-planche 1), un corps (2-planche 1), une tige (3-planche 1) et un couteau (4-planche 1) et elle est munie d'une clé dentelée (avec des cannelures) (planche 2) spécialement adaptée pour manoeuvrer la vanne et sans permettre à des personnes autres que ceux habilités par les régies et les offices de distribution de l'eau potable d'y accéder ou manoeuvrer.
Patent MA-20150176-A1 (MA)
Title: Plateforme suiveur de soleil basee sur un systeme embarque capteurs integre de faible cout pour une production energetique optimale
Inventor: WADI CHALGHAM
IPC: F24S50/20
Filed: 2013-11-26
Abstract: Notre invention a pour objectif d'améliorer ie rendement et ia sécurité des panneauxsolaires, des panneaux solaires é concentration et des chauffe-eaux solaires. Nous apportonsune solution électronique pour traqueurs basée sur des prises de décisions intelligentesrelatives :ei des données environnementales captées.
Patent MA-37511-A1 (MA)
Title: Bio nano-composite a base de biopolymere et cellulose nanocristalline
Inventor: ABOU EL KACEM QAISS
IPC: C08L5/08
Filed: 2014-11-11
Abstract: Un matériau bio-nanocomposite biodégradable a base de biopolymère et de nanocharge extraite a partir de fibre de doum, ayant des propriétés mécaniques et barrière intéressante.
Patent MA-37729-A1 (MA)
Title: Composition pharmacologique des huiles esentielles de la menthe pouliot citronnelle, origon, thyme, bigaradier et palmarosa a effet antibacterien sur l'aggregatibacter actinomycetemcomitans
Inventor: LAKHDER LEILA
IPC: A61P43/00
Filed: 2014-12-31
Abstract: Composition chimique :l'analyse chimique de l’huile essentielle étudiée a mis en évidence les constituantsmajeurs suivants : r(+)-pulégone (71.48%) et carvone (5,66%) (tableau 1).Activité antibactérienne essai de diffusion en puits:apres la période d’incubation (48h), des zones d'inhibition de croissance bactériennesur gélose sont obtenues et mesurées par un pied à coulisse (tableau 2). Cependant,aucun halo d'inhibition n'est obtenu pour les contrôles négatifs (tween 80 pur et dilué a10%). Concernant, le témoin de croissance utilisé, une croissance bactérienne sousforme d'un film recouvrant la gélose est obtenue. Le diamètre moyen des zonesd'inhibition induits par la doxycycline (22,67 i 1,15 mm) est significativement plus petitque celui produit par l’huile essentielle testée a l'état pur (39 i 1,00 mm). Les diamètresdes zones d'inhibition observés pour l’huile essentielle de menthe pulegium l. à l'étatbrut, ont montré des valeurs supérieures à 20 mm (tableau 2), traduisant une fortesensibilité de la souche aggregatibacter actinomycetemcomitans clone ip2 a l’huileétudiée.Essai de microdilution :les valeurs enregistrées de cmi, cmb et rapport cmb/cmi sont représentés dans letableau 3. La cmi (0,3%) et la cmb (0,6%) obtenues témoignent d'une activitéantibactérienne effective de l’huile essentielle mentha pulegium l. Dans l'étude deshapiro et al.1994, une valeur de cmi similaire (0,3%) sur aa (clone non ipz) a ététrouvée pour mentha piperita, qui est de la méme espece (mentha) que mentha pulegium,ce qui vient appuyer nos résultats.Le rapport cmb/cmi obtenu est inférieur à 4, ce qui renseigne sur la nature de l'effetantibactérien de l’huile essentielle testée qui s'avère ainsi bactéricide.
Patent MA-37861-A1 (MA)
Title: Procede d'elaboration d'un coagulant pour le traitement de lixiviat des centres de stockage de dechet menager et assimile
Inventor: HASSAN CHAAIR
IPC: C02F1/52
Filed: 2015-02-19
Abstract: L'invention a pour objectif un procédé d'élaboration d'un coagulant pour le traitement de lixiviat. De façon caractéristique, on prépare une matière première contenant de l'argile et/ou de la boue résultant d'une filière de traitement d'eau potable, de la chaux et d'un minerai contenant du fer et/ou de l'aluminium. Cette matière première est soumise par la suite à un traitement thermique en vue d'obtenir un composé actif. Ce procédé s'applique de façon générale au traitement des effluents aqueux contenant des polluants, plus particulièrement aux lixiviats générés par les centres de stockage de déchet ménager et assimilé. L'invention concerne un procédé d'élaboration d'un produit coagulant qui peut être utilisé en particulier pour le traitement des iixiviats de centre de stockage des déchets ménageret assimilé.
Patent UY-23449-A1 (UY)
Inventor: CLOZEL JEAN-PAUL
IPC: A61K31/551
Filed: 1992-07-22
Abstract: An antihypertensive combination product contains a mixture of a tetrahydronaphthalene derivative of the general formula <IMAGE> in which R<1> is halogen, R<2> is lower alkoxy-lower-alkylcarbonyloxy, X is C2-C8-alkylene and A is benzimidazolyl which is optionally substituted on the N atom by alkyl with 1 to 12 C atoms,  and of a pyridazodiazepine of the general formula <IMAGE> in which R<4> is aralkyl with 1 to 6 C atoms in the alkyl radical and phenyl in the aryl radical, where the phenyl radical is optionally monosubstituted by halogen, alkoxy with 1 to 6 atoms or phenyl, R<5> and R<6> are each, independently of one another, hydrogen or alkyl with 1 to 6 C atoms and R<7> and R<8> are hydrogen or together are an oxo group, in the form of their free bases, their hydrates or their pharmaceutically utilisable salts for concurrent, separate or sequential use.
Patent UY-23965-A1 (UY)
Title: Sistema de escurrimiento de aguas pluviales acumuladas sobre el techo flotante de un tanque de almacenamiento de productos liquidos
Inventor: WITTER ALDYR
IPC: B65D88/38
Filed: 1995-05-22
Abstract: La presente invención se refiere a distintos dispositivos añadidos al techo flotante de un tanque de almacenamiento de productos líquidos que promueven una más grande eficiencia del escurrimiento del agua de la lluvia que se acumula sobre dicho techo. Tales dispositivos son: (a) aperturas en el techo, denominadas captadores, que se alargan en forma descendiente en embudamiento suave, terminando en una tubería proveída de pequeña inclinación, que desemboca en: - (b) un recipiente incorporado al techo flotante, denominado caja de drenaje, cada caja de drenaje recibiendo tuberías provenientes de distintos captadores, estando los terminales de las referidas tuberías, ubicados dentro de la caja de drenaje, proveídos de: (c) válvulas de extremidad de escurrimiento en forma de una grieta, que se cierra ante valores bajod de contrapresión, con la finalidad de impedir el paso de productos líquidos del interior del tanque hacia el techo, estando proveídas de: pantallas montadas en marcos sobre los referidos captadors, con miras a retener los detritos y evitar la formación de vórtice. El sistema se ilustra en la figura 1.
Patent UY-24813-A1 (UY)
Title: Nuevas preparaciones medicamentosas acuosas para la produccion de aerosoles libres de gas propulsor
Inventor: FREUND BERNHARD
IPC: A61K9/12
Filed: 1997-12-17
Abstract: El presente invento se refiere a una preparación farmacéutica en la producción de aerosoles libre de propelentes para inhalación para el tratamiento de enfermedades pulmonares, caracterizada en que la preparación farmacéutica es una solución acuosa de un ingrediente activo que comprende un agente complejeante en donde el ingrediente activo es seleccionado del grupo formado por Betamiméticos, Anticolinérgicos, Antialérgicos y/o Antihistamínicos; en donde el solvente es agua, que contiene eventualmente una cantidad de etanol hasta un 70% (v/v). El ingrediente activo es seleccionado del grupo formado por Fenoterol, Bromuro de Ipatropium, Salbutamol, Bromuro de Tiotropium, y el agente complejeante es EDTA, ácido nitriloacético, ácido cítrico, ácido ascórbico o sales de los mismos.
Patent UY-26537-A1 (UY)
Title: Dispositivo osmótico que contiene ranitidina y un agente procinético
Inventor: FAOUR JOAQUINA
IPC: A61K9/22
Filed: 2001-01-12
Abstract: La presente invención proporciona un dispositivo osmótico que contiene ratinidina de liberación controlada en el núcleo en combinación con un agente procinético en un recubrimiento externo de liberación rápida. Se puede utilizar un amplio rango de agentes procinéticos. Las realizaciones particulares de la invención proveen un dispositivo osmótico que tienen perfiles determinados de liberación. Una realización del dispositivo osmótico incluye un recubrimiento externo que ha sido revestido con pulverizado más que con compresión. El dispositivo con núcleo recubierto externamente con pulverizado es más pequeno y más fácil de tragar que el dispositivo similar que tiene un recubrimiento externo aplicado por compresión. El dispositivo es útil para el tratamiento de trastornos relacionados con el ácido gástrico. Se puede progrmar que el dispositivo se administre una o dos veces al día. Las cantidades de ranitidina y agente procinético pueden ser variadas. Una realización provee dos cargas diferentes de ranitidina (una de liberación rápida y la otra de liberación controlada) y una carga de liberación rápida del agente procinético.
Patent UY-30041-A1 (UY)
Title: Triazolopiridazinas como moduladores de quinasa
Inventor: MARKOTAN THOMAS P
IPC: C07D405/14
Filed: 2006-12-19
Abstract: La invención se refiere a compuestos de triazolopiridazina de fórmula I: donde R1, R5, R6, R7, R8, y A son según lo definido en la presente, al uso de tales compuestos como moduladores de proteína tirosina quinasas, en especial inhibidores de c-Met y al uso de tales compuestos para reducir o inhibir la actividad de quinasa de c-Met en una célula o en un sujeto, y modular la expresión de c-Met en una célula o sujeto, y al uso de tales compuestos para prevenir o tratar en un sujeto un trastorno proliferativo celular y/o trastornos relacionados con c-Met. La presente invención se refiere adicionalmente a composiciones farmacéuticas que comprenden tales compuestos de la presente invención y a métodos para tratar afecciones como cáncer u otros trastornos proliferativos.
Patent UY-30382-A1 (UY)
Title: Composicion farmaceutica antiacida en forma de polvo, preparacion farmaceutica que la comprende y proceso para su preparacion
Inventor: LOS MARIO ATILIO
IPC: A23L29/256
Filed: 2007-05-31
Abstract: Composición farmacéutica antiácida efectiva en polvo que protege las mucosas gásticas, útil para preparar con agua una solución/suspensión oral, comprendiendo: alginato de sodio, antiácido soluble o combinación de antiácidos, inhibidor de bomba protónica, diluyentes y edulcotrantes. Aproximadamente 30% del alginato junto con el inhibidor de la bomba protónica se encuentran distribuidos homogéniamente sobre el antiácido o combinación de antiácidos, conteniendo el alginato remanente una humedad inferior al 2% . Proceso para elaborarla. El 70% aproximado de alginato y otros componentes favorece la dispersikón del resto, incrementando la viscosidad de la solución/suspensión al reconstituir homogéneamente la composición en menos de 2 minutos.
Patent ES-150350-A1 (ES)
Title: Un procedimiento para esponjar guisantes secos
Filed: 1942-04-10
Abstract: Procedimiento para esponjar guisantes secos por ebullición o evaporacióncon adición de un ingrediente que acelera el esponjamiento; caracterizado porque se añaden citratos alcalinos.
Patent ES-184351-A1 (ES)
Title: Perfeccionamientos en los aparatos para separar o limpiar semillas y productos similares
Filed: 1948-06-30
Abstract: Perfeccionamientos en los aparatos para separar por limpiar semillas y productos similares del tipo que tiene un conducto por el cual circula una corriente ascendente de aire y que contiene varias válvulas interconectadas dispuestas una al lado de otra y que están preparadas para abarcar conjuntamente toda la superficie transversal del conducto caracterizados porque las válvulas están interconectadas de tal modo que dos de ellas situadas una al lado del otra son ajustables en direcciones opuestas.